Zaliha: Negotiations on bivalent vaccines with Pfizer ongoing

 

Health Minister Dr Zaliha Mustafa said the Health Ministry is still in the process of negotiating with Pfizer Sdn Bhd in regard to the Covid-19 bivalent vaccines.

“I’ll be meeting them, maybe in a few weeks’ time, then we’ll settle on that matter and hopefully we can get the bivalent vaccines as soon as possible,” she said after launching the Elekta Versa HD Linear Accelerator (LINAC) system in conjunction with World Cancer Day 2023 at KPJ Damansara Specialist Hospital, today.

Zaliha (above) said this when asked by reporters on the update of the vaccine that was earlier estimated to arrive in Malaysia by the end of January.

On Jan 2, she was reported as saying that the Covid-19 bivalent vaccines will be supplied to the country soon, following the approval of the conditional registration given by the Drug Control Authority.

Meanwhile, at the event, Zaliha said although positive progress has been achieved in cancer management, 63.7 percent of all reported cancer cases were already in stages three and four when they were diagnosed.

“At the third and fourth stages, the patient’s survival rate drops significantly. This could be because of late detection, lack of awareness, poor screening rates or limited medical care availability, especially in the non-urban area.

“While treatment is essential, cancer awareness must also be prioritised,” she said.

Zaliha said there was also an increase of 11 percent in cancer cases recorded from 2012 until 2015 - bringing the number to 115,238 cases from 103,507 cases from 2007 to 2011.

In 2020, she said some 48,639 new cancer cases were recorded with 29,530 deaths due to the disease.

LINAC is a sophisticated linear accelerator system technology that is utilised to provide the most accurate and safe form of treatment for cancer patients.

This technology comes with state-of-the-art features namely the 6D robotic couch, Surface Guided Catalyst HD and the latest version of the treatment planning system, the Monaco and Oncology Information System (Mosaiq).

- Bernama